Filing Details

Accession Number:
0001321732-24-000102
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-24 19:29:53
Reporting Period:
2024-09-20
Accepted Time:
2024-09-24 19:29:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1321732 Penumbra Inc PEN Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1651323 Adam Elsesser One Penumbra Place
Alameda CA 94502
Ceo And President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-09-20 2,853 $195.26 894,729 No 4 S Indirect By Trust
Common Stock Disposition 2024-09-20 1,747 $195.91 892,982 No 4 S Indirect By Trust
Common Stock Disposition 2024-09-20 299 $197.21 892,683 No 4 S Indirect By Trust
Common Stock Disposition 2024-09-20 5,192 $198.44 887,491 No 4 S Indirect By Trust
Common Stock Disposition 2024-09-20 4,656 $198.98 882,835 No 4 S Indirect By Trust
Common Stock Disposition 2024-09-20 253 $199.99 882,582 No 4 S Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,000 Direct
Footnotes
  1. The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
  2. This transaction was executed in multiple trades at prices ranging from $194.72 to $195.71. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
  3. Shares are held by the Siegel/Elsesser Revocable Trust.
  4. This transaction was executed in multiple trades at prices ranging from $195.72 to $196.25. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
  5. This transaction was executed in multiple trades at prices ranging from $197.09 to $197.39. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
  6. This transaction was executed in multiple trades at prices ranging from $197.95 to $198.71. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
  7. This transaction was executed in multiple trades at prices ranging from $198.73 to $199.68. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
  8. This transaction was executed in multiple trades at prices ranging from $199.75 to $200.22. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.